Patent Assignment
Reel/Frame 017073/0257
Merger
Recorded: 2005-12-12
Pages: 39
Assignor
FUJISAWA PHARMACEUTICAL CO., LTD.
Executed: 2005-04-01
Assignee
ASTELLAS PHARMA INC.
3-11, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU, TOKYO, JAPAN
Covered Properties
(175)
Combined Bottle and Cap
Patent:
313,176 →
Application:
07/075,082 →
Bottle
Patent:
306,967 →
Application:
07/127,691 →
Medical Fluid Container
Patent:
323,389 →
Application:
07/338,125 →
Oxaspiro(2,5)Octane Derivative
Patent:
5,789,405 →
Application:
07/711,420 →
New Polypeptide Compound and a Process for Preparation Thereof
Patent:
5,376,634 →
Application:
07/715,961 →
Trifluoromethylketone Derivatives, Processes for Preparation Thereof and Use Thereof
Patent:
5,296,591 →
Application:
07/805,610 →
Ceohalosponin Intermediates
Patent:
5,252,731 →
Application:
07/831,504 →
Ethanolamine Derivatives Having Sympathomimetic and Anti-Pollakiuria Activities
Patent:
5,387,710 →
Application:
08/117,163 →
Elastase-Inhibiting Peptides Bearing a C-Terminal Trifluoromethylketone Moiety
Patent:
5,430,025 →
Application:
08/158,981 →
New Antimicrobial Polypeptide Compound, a Pharmaceutical Composition Comprising the Same, and a Method for Treating Infectious Diseases
Patent:
5,502,033 →
Application:
08/218,883 →
Bradykinin Antagonist Quinolines
Patent:
5,563,162 →
Application:
08/233,771 →
Depsipeptide Derivatives, Production Thereof and Use Thereof
Patent:
5,514,773 →
Application:
08/295,782 →
Pyrazolopyridine Compounds for the Treatment of Anemia
Patent:
5,643,938 →
Application:
08/338,539 →
Process for the Production of Alpha-Human Atrial Natriuretic Polypeptide
Patent:
6,403,336 →
Application:
08/370,356 →
Treatment of Insulin-Resistant Diabetes
Patent:
5,674,845 →
Application:
08/412,222 →
Tissue Plasminogen Activator
Patent:
5,648,250 →
Application:
08/412,859 →
Beta-Alanine Derivative and a Process for the Preparation Thereof
Patent:
6,380,215 →
Application:
08/495,572 →
Cyclodepsipeptide Compound
Patent:
5,646,244 →
Application:
08/605,064 →
Heterocyclic Compounds
Patent:
5,708,173 →
Application:
08/660,393 →
Benzamide Derivatives as Vasopressin Antagonists
Patent:
6,211,242 →
Application:
08/722,243 →
Heterobicyclic derivatives
Patent:
6,426,345 →
Application:
08/793,451 →
Use of 5HT3 Antagonist to Treat Impotence
Patent:
5,750,537 →
Application:
08/793,798 →
Pyridopyrimidones, Quinolines and Fused N-Heterocycles as Bradykinin Antagonists
Patent:
5,994,368 →
Application:
08/809,416 →
Cyclic Hexapeptides Having Antibiotic Activity.
Patent:
6,107,458 →
Application:
08/809,723 →
Tissue Plasminogen Activator
Patent:
5,840,533 →
Application:
08/811,949 →
N-Acylpiperidinylcarbonylaminocarboxylic Acids and Their Use as Glycoprotein Iib/Iiia Antagonists and Fibrinogen-Blood Platelets Binding Inhibitors
Patent:
6,384,028 →
Application:
08/894,795 →
Cyclic Peptide Nuclei and Derivatives Thereof
Patent:
5,952,299 →
Application:
08/913,365 →
8-Substituted Quinazolines, Quinoxalines and Benzopyridazines
Patent:
5,922,711 →
Application:
08/933,354 →
New Use of Pyrazolopyridine Compound
Patent:
6,232,324 →
Application:
08/945,175 →
Benzamide Derivatives and Their Use as Vasopressin Antagonists
Patent:
6,054,457 →
Application:
08/973,103 →
Depsipeptide Derivative, Process for Production Thereof, and Novel Intermediate Therefor
Patent:
5,856,436 →
Application:
08/973,718 →
Heterocyclic Compounds as Bradykinin Antagonists
Patent:
6,008,229 →
Application:
09/029,852 →
Quinoline Compounds as H+-Atpases
Patent:
6,008,230 →
Application:
09/051,093 →
Piperazine Derivatives as Tachykinin Antagonists
Patent:
6,087,357 →
Application:
09/091,269 →
Thiazolylbenzofuran Derivatives and Pharmaceutical Compositions Containing Them
Patent:
5,994,378 →
Application:
09/101,766 →
Beta-Lactam Antibiotic-Containing Tablet and Production Thereof
Quinoline Derivatives as Bradykinin Agonists
Patent:
6,015,818 →
Application:
09/117,453 →
Process for the Deacylation of Cyclic Lipopeptides
Patent:
6,207,434 →
Application:
09/142,045 →
Quinoline Derivatives, Processes for Their Preparation and Their Use as Medicaments
Patent:
6,083,959 →
Application:
09/147,193 →
Cyclic Lipopeptide Acylase
Patent:
6,146,872 →
Application:
09/147,352 →
Hematopoietic Stem Cell Proliferating Agents
Patent:
6,495,365 →
Application:
09/147,689 →
Bradykinin Antagonist Quinolines
Patent:
6,169,095 →
Application:
09/228,973 →
Transmembrane Trapping Methods
Patent:
6,582,905 →
Application:
09/230,378 →
New Compound
Patent:
6,265,536 →
Application:
09/248,267 →
Process for Producing Depsipeptide Derivatives and Novel Intermediates Therefor
Patent:
6,235,875 →
Application:
09/269,743 →
Cyclic Hexapeptides Having Antibiotic Activity
Patent:
6,399,567 →
Application:
09/308,218 →
Cyclohexapeptides Having Antimicrobial Activity
Agent for Expression of Long-Term Potentiation of Synaptic Transmission Comprising Compound Having Brain Somatostatin Activation Property
Patent:
6,344,358 →
Application:
09/321,745 →
Novel Process for Producing Alcohols
Patent:
6,271,425 →
Application:
09/355,345 →
Preventives and Remedies for Hyperphosphatemia
Patent:
6,303,624 →
Application:
09/380,617 →
Heterocyclic Compounds as Bradykinin Antagonists
Patent:
6,100,284 →
Application:
09/419,684 →
Benzimidazole Derivatives as Bradykinin Agonists
Patent:
6,127,389 →
Application:
09/422,075 →
New Echinocandine Derivatives with Antimicrobial Activity
Patent:
6,331,521 →
Application:
09/423,654 →
Oxazole Compounds Useful as PGE2 Agonists and Antagonists
Patent:
6,245,790 →
Application:
09/424,253 →
Human T Cell-Engrafted Mouse, Method for Developing Same and Use Thereof
Compound
Patent:
6,232,290 →
Application:
09/446,101 →
Production Process
Patent:
6,291,680 →
Application:
09/446,359 →
Novel Crystal of Depsipeptide Derivative and Process for Producing the Same
Patent:
6,346,603 →
Application:
09/530,591 →
Animal Model for Allergic Disorders
Patent:
7,094,946 →
Application:
09/548,290 →
Naphthalene Derivatives
Patent:
6,303,649 →
Application:
09/582,173 →
Benzamide Derivatives as Vasopressin Antagonists
Patent:
6,495,542 →
Application:
09/600,857 →
Heterocyclic compounds as bradykinin antagonists
Patent:
6,344,462 →
Application:
09/604,526 →
Benzamide derivatives having a vasopressin antagonistic activity
Patent:
6,316,482 →
Application:
09/614,132 →
Preventives/Remedies for Skin Aging
Patent:
6,610,748 →
Application:
09/622,053 →
Fullerene Derivatives
Patent:
6,765,098 →
Application:
09/622,915 →
Propanolamine Derivatives
Patent:
6,495,546 →
Application:
09/646,878 →
Antibacterial Agents
Patent:
6,369,050 →
Application:
09/647,925 →
Process for the Deacylation of Cyclic Lipopeptides
Patent:
6,573,084 →
Application:
09/656,417 →
Process for the Deacylation of Cyclic Lipopeptides
Patent:
6,537,789 →
Application:
09/656,420 →
Cyclic Lipopeptide Acylase
Patent:
6,372,474 →
Application:
09/659,335 →
Remedies for Male Sterility
Patent:
6,521,656 →
Application:
09/701,385 →
Imidazole Compounds
Patent:
6,359,145 →
Application:
09/764,995 →
Novel Manufacturing Method
Stabilized Pharmaceutical Composition in Lyophilized Form
Patent:
6,774,104 →
Application:
09/786,125 →
Oxazole Compounds as Prostaglandin E2 Agonists or Antagonists
Patent:
6,437,146 →
Application:
09/787,433 →
N- (R)] -1-[3-(4-Piperidyl)Propionyl} -3PIPERIDYLCARBONYL]-2(S)-Aceylamino-B Alanine Trihydrate,Compositions Thereof,and Methods for Its Use
Patent:
6,538,007 →
Application:
09/806,483 →
Cyclic Tetrapeptide Compound and Use Thereof
Patent:
6,656,905 →
Application:
09/806,500 →
Vitreous Form of Known Bradykinin Antagonist
Patent:
6,509,468 →
Application:
09/807,421 →
Beta-alanine derivative and a process for the preparation thereof
Application:
09/865,420 →
Publication:
US 2001/0051730
Imidazole Compounds and Medicinal Use Thereof
Patent:
7,060,721 →
Application:
09/869,135 →
Amide Compounds
Patent:
6,710,043 →
Application:
09/869,962 →
Heterocyclic Compound, Composition and Method for Inhibiting Adenosine Deaminase
Patent:
6,596,738 →
Application:
09/926,134 →
Cyclic Hexapeptides Having Antibiotic Activity
Patent:
6,884,868 →
Application:
09/926,385 →
Combination of a cyclic hexapeptide with antifungal drugs for treatment of fungal pathogens
Patent:
6,875,740 →
Application:
09/926,679 →
Cyclic Hexapeptide Derivatives
Amyloid Beta Protein Agglutination-Controlling Factor
Patent:
6,960,435 →
Application:
10/030,269 →
Macrolide compound
Application:
10/031,339 →
Agent for Expression of Long-Term Potentiation of Synaptic Transmission Comprising Compound Having Brain Somatostatin Activation Property
Process for the Preparation of Indole Derivatives or Salts Thereof
Patent:
6,515,141 →
Application:
10/049,651 →
Cyclic Lipopeptide Acylase
Heterobicyclic Derivatives
Propanolamine Derivatives
Infusion Container and Method for Storing Freeze-Dried Medicine
Application:
10/089,165 →
Substituted Dipeptides Having Nos Inhibiting Activity
Patent:
6,825,200 →
Application:
10/111,412 →
Aminoalcohol derivatives useful for the treatment of gastrointestinal disorders
Application:
10/129,134 →
Imidazole Compounds and Their Use as Adenosine Deaminase Inhibitors
Beta-Alanine Derivatives and Their Use as Receptor Antagonists
Hematopoietic Stem Cell Proliferating Agents
Pyridine derivatives useful as cyclooxygenase inhibitor
Application:
10/204,003 →
Publication:
US 2003/0119877
Peptide Compounds
Process for the production of alpha-human atrial natriuretic polypeptide
Application:
10/279,061 →
Publication:
US 2003/0170811
Amide Compounds for the Potentiation of Cholinergic Activity
Process for the Preparation of a Piperazine Derivative
Benzhydryl Derivatives
Reduced FK228 and Use Thereof
Triazole Derivatives
Tablet Comprising a Synthetic Sweetener Having a Mean Particle Size of Not Less Than 150U
Application:
10/346,120 →
Publication:
US 2003/0129227
Inducible High Expression System
Aminoalcohol Derivatives
Preventatives/remedies for skin aging
Application:
10/405,701 →
Publication:
US 2003/0203853
Use
Application:
10/414,150 →
Publication:
US 2003/0232867
Process for Producing Anhydride of Aminothiazole Derivative
Nootropic effect enhancer
Application:
10/433,569 →
Publication:
US 2004/0029894
Silenced anti-cd28 antibodies and use thereof
Application:
10/450,384 →
Publication:
US 2004/0116675
Neurotrophic tacrolimus analogs
Application:
10/451,361 →
Publication:
US 2004/0077676
Echinocandin derivatives, pharmaceutical compositions containing same and use thereof as drugs
Application:
10/468,142 →
Publication:
US 2004/0082757
Compound
Application:
10/469,233 →
Publication:
US 2005/0261177
Anti-osteopontin antibody and use thereof
Application:
10/473,134 →
Publication:
US 2004/0234524
Method for Increasing Productivity of Secondary Metabolite by Conferring Drug-Resistant Mutations
Cephem Compounds
Novel Guasonine Triphosphate-Binding Protein -Coupled Receptor Place 6002312, Its Gene and Production and Use of the Same
Application:
10/475,868 →
Publication:
US 2004/0147720
Aminoalcohol Derivatives
Application:
10/477,751 →
Publication:
US 2004/0138462
Pyrazolopyrazine Compound and Pharmaceutical Use Thereof
Imidazole Derivatives as Adenosine Deaminase Inhibitors
Medicinal Use of Histone Deacetylase Inhibitor and Method of Evaluating Antitumor Effect Thereof
Recombinant Anti-Osteopontin Antibody and Use Thereof
Method for improving dissolution of poorly dispersible medicaments
Application:
10/491,887 →
Publication:
US 2005/0003001
Methods of Eavaluating Phosphatase Inhibitors
Thiazole derivative and pharmaceutical use thereof
Application:
10/494,033 →
Publication:
US 2005/0004134
Aminopyrimidine compounds, processes for their preparation and pharmaceutical compositions containing them
Application:
10/498,016 →
Publication:
US 2005/0043315
Imidazole 4-Carboxamide Compounds with Adenosine Deaminase Inhibiting Activity
Aminoalcohol derivatives as beta-3 adrenergic receptor agonists
Application:
10/504,990 →
Publication:
US 2005/0090669
ISOFORMS OF NUCLEAR RECEPTOR RXR a
Application:
10/507,696 →
Publication:
US 2005/0203283
Nuclear receptor err y 3
Application:
10/507,700 →
Publication:
US 2006/0148030
Depsipeptide for therapy of kidney cancer
Neurotrophic factor production accelerator
Application:
10/509,336 →
Publication:
US 2006/0069104
Polynucleotide Encoding a 35 Kda Protein Thats Binds to WF00144
Remedy for urinary frequency and urinary incontinence
Application:
10/519,415 →
Publication:
US 2005/0261164
Novel method of selecting immunosuppressant having little thrombocytopenic effect
Application:
10/519,678 →
Publication:
US 2006/0135401
New Process
Method of Inhibiting Nonspecific Interaction Between Molecules on Solid Phase Support
Neurotrophic factor production promoter
Application:
10/529,784 →
Publication:
US 2005/0282865
Method of selecting novel immunosuppressant
Application:
10/540,546 →
Publication:
US 2007/0123452
Aminoalcohol Derivatives
Amide compounds
Application:
10/618,743 →
Publication:
US 2004/0014745
Calcium channel target for controlling epidermal keratinocyte growth in psoriasis, and basal and squamous cell carcinomas
Application:
10/641,158 →
Publication:
US 2004/0087480
Pyridazinone Compound and Pharmaceutical Use Thereof
Application:
10/653,129 →
Publication:
US 2004/0067955
Cephem Compounds
Pyrazole Derivatives
Method for the treatment of parkinson's disease comprising administering an A1A2a receptor dual antagonist
Application:
10/716,865 →
Publication:
US 2004/0152659
Aroyl-Piperazine Derivatives, Their Preparation and Their Use as Tachykinin Antagonists
Pyrrolopyridazine Derivatives
Hdac Inhibitor
Inhibitor of cox
Application:
10/758,253 →
Publication:
US 2004/0157891
Thiazole Derivatives
Stabilized Pharmaceutical Composition in Lyophilized Form
Method for identifying myelodysplastic syndrome-specific genes
Application:
10/824,536 →
Publication:
US 2005/0233330
Cephem compounds
Application:
10/833,088 →
Publication:
US 2005/0004094
Antitumor agent
Application:
10/834,080 →
Publication:
US 2005/0187148
Sorbitol dehydrogenase, gene encoding the same and use thereof
Application:
10/844,403 →
Publication:
US 2004/0235105
Fullerene Derivatives
Benzimidazole compounds
Application:
10/860,139 →
Publication:
US 2005/0014812
New compound
Application:
10/860,508 →
Publication:
US 2005/0004014
Therapeutic Agent for Soft Tissue Sarcoma
Cephem Compounds
Antitumor Agent
Pyrazine Derivatives and Pharmaceutical Use Thereof
2-Cyanopyrrolidinecarboxamide Compound
New methods
Application:
10/996,589 →
Publication:
US 2005/0245540
Amyloid-Beta Protein Aggregation-Regulating Factors
Aminoalcohol Derivatives
Therapeutic Combination of a Pneumocandin Derivative and an Antifungal Agent
Method for treating erectile dysfunction
Application:
11/038,194 →
Publication:
US 2005/0182084
Concomitant drugs
Application:
11/068,747 →
Publication:
US 2005/0197376
Pyrazine Derivatives and Pharmaceutical Use Thereof
Related Assignments
(23)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignors Interest.
Mar 17, 1988
From: OKUDA, KIYOSHI; OKADA, KIYONORI; FUKUOKA, HISATOMI; OHTOMO, KAZUMI
To: FUJISAWA PHARMACEUTICAL CO., LTD.
Reel/Frame 004837/0474 →
Assignment of Assignors Interest.
Jan 10, 1990
From: MATSUURA, MASARU; FUJII, MASATSUGU
To: FUJISAWA PHARMACEUTICAL CO., LTD.
Reel/Frame 005212/0869 →
Assignment of Assignors Interest.
Sep 9, 1991
From: AOKI, OSAMU; OKADA, KIYONORI; SUNAGO, SEIZO; FUTAGAWA, HITOSHI
To: FUJISAWA PHARMACEUTICAL CO., LTD.
Reel/Frame 005826/0178 →
Assignment of Assignors Interest.
Apr 23, 1993
From: HEMMI, KEIJI; SHIMA, ICHIRO; IMAI, KEISUKE; TANAKA, HIROKAZU
To: FUJISAWA PHARMACEUTICAL CO., LTD.
Reel/Frame 006515/0069 →
Assignment of Assignor's Interest
Jun 17, 1993
From: OKU, TERUO; KASAHARA, CHIYOSHI; OHKAWA, TAKEHIKO; HASHIMOTO, MASAHI
To: FUJISAWA PHARMACEUTICAL CO., LTD.
Reel/Frame 006585/0613 →
Assignment of Assignor's Interest
May 26, 1994
From: IWAMOTO, TOSHIRO; FUJIE, AKIHIKO; NITTA, KUMIKO; TSURUMI, YASUHISA
To: FUJISAWA PHARMACEUTICAL CO., LTD.
Reel/Frame 006990/0060 →
Assignment of Assignor's Interest
Jun 2, 1994
From: OKU, TERUO; KAYAKIRI, HIROSHI; SATOH, SHIGEKI; ABE, YOSHITO
To: FUJISAWA PHARMACEUTICAL CO., LTD.
Reel/Frame 007012/0721 →
Assignment of Assignor's Interest
Sep 14, 1994
From: IWAMOTO, TOSHIRO; FUJIE, AKIHIKO; NITTA, KUMIKO; TSURUMI, YASUHISA
To: FUJISAWA PHARMACEUTICAL CO., LTD.
Reel/Frame 007133/0188 →
Assignment of Assignor's Interest
Oct 11, 1994
From: NISHIYAMA, HITOSHI; OHGAKI, MASARU; YAMANISHI, RYO; HARA, TOSHIHIKO
To: FUJISAWA PHARMACEUTICAL CO., LTD.
Reel/Frame 007276/0013 →
Assignment of Assignor's Interest
Oct 20, 1994
From: SHIOKAWA, YOUICHI; NAGANO, MASANOBU; TANIGUCHI, KIYOSHI; TAKE, KAZUHIKO
To: FUJISAWA PHARMACEUTICAL CO., LTD.
Reel/Frame 007170/0856 →
Assignment of Assignor's Interest
Jun 9, 1995
From: IWAMOTO, TOSHIRO; FUJIE, AKIHIKO; NITTA, KUMIKO; TSURUMI, YASUHISA
To: FUJISAWA PHARMACEUTICAL CO., LTD.
Reel/Frame 007507/0143 →
Assignment of Assignor's Interest
Oct 19, 1995
From: OHKUBO, MITSURU; TAKAHASHI, FUMIE; YAMANAKA, TOSHIO; SAKAI, HIROYOSHI
To: FUJISAWA PHARMACEUTICAL CO., LTD.
Reel/Frame 007855/0404 →
Assignment of Assignor's Interest
Apr 25, 1996
From: NISHIYAMA, HITOSHI; OHGAKI, MASARU; YAMANISHI, RYO; HARA, TOSHIHIKO
To: FUJISAWA PHARMACEUTICAL CO., LTD.
Reel/Frame 007917/0842 →
Assignment of Assignor's Interest
Feb 13, 1997
From: KOHNO, YUTAKA; NAGATOMI, ITSUO; HANAOKA, KAORI
To: FUJISAWA PHARMACEUTICAL CO., LTD.
Reel/Frame 008353/0829 →
Assignment of Assignor's Interest
Mar 17, 1997
From: SHIMAZAKI, NORIHIKO; WATANABE, SHINYA; SAWADA, AKIHIKO; HEMMI, MITSUE, HEIR OF KEIJI HEMMI (DECEASED)
To: FUJISAWA PHARMACEUTICAL CO., LTD.
Reel/Frame 008406/0862 →
Assignment of Assignor's Interest
Jun 20, 1997
From: NOMURA, KAZUHIKO; YAMAGUCHI, ISAMU
To: FUJISAWA PHARMACEUTICAL CO., LTD.
Reel/Frame 008746/0190 →
Assignment of Assignor's Interest
Jul 23, 1997
From: OHKI, HIDENORI; TOMISHIMA, MASAKI; YAMADA, AKIRA; TAKASUGI, HISASHI
To: FUJISAWA PHARMACEUTICAL CO., LTD.
Reel/Frame 008623/0379 →
Assignment of Assignor's Interest
Jan 30, 1998
From: SETOI, HIROYUKI; OHKAWA, TAKEHIKO; ZENKOH, TATSUYA; HEMMI, MITSUE, HEIR OF KENIJI HEMMI
To: FUJISAWA PHARMACEUTICAL CO., LTD.
Reel/Frame 009373/0925 →
Assignment of Assignor's Interest
Jan 30, 1998
From: SHIMAZAKI, NORIHIKO; WATANABE, SHINYA; SAWADA, AKIHIKO; HEMMI, KEIJI (DECEASED) BY HIS HEIR; MITSUE HEMMI
To: FUJISAWA PHARMACEUTICAL CO., LTD.
Reel/Frame 010780/0552 →
Assignment of Assignor's Interest
Jun 9, 1999
From: OKU, TERUO; KAYAKIRI, HIROSHI; SATOH, SHIGEKI; ABE, YOSHITO
To: FUJISAWA PHARMACEUTICAL CO., LTD.
Reel/Frame 010005/0520 →
Assignment of Assignor's Interest
Nov 4, 2003
From: SAKURAI, MINORU; WASHIZUKA, KENICHI; HAMASHIMA, HITOSHI; TOMISHIMA, YASUYO
To: FUJISAWA PHARMACEUTICAL CO., LTD.
Reel/Frame 014656/0794 →
Assignment of Assignor's Interest
Oct 29, 2004
From: NAOE, YOSHINORI; SASAKAWA, YUKA
To: FUJISAWA PHARMACEUTICAL CO., LTD.
Reel/Frame 015957/0007 →
Merger
May 9, 2005
From: FUJISAWA PHARMACEUTICAL CO., LTD.
To: ASTELLAS PHARMA INC.
Reel/Frame 016195/0824 →